107 related articles for article (PubMed ID: 1791330)
1. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
2. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].
Obana M; Tomizawa I; Takizawa Y; Nitta Y; Sagara H; Seo T; Sato J; Tsunoda T; Ota S; Machii A
Kansenshogaku Zasshi; 1991 Sep; 65(9):1165-82. PubMed ID: 1761896
[TBL] [Abstract][Full Text] [Related]
4. [A clinical experience of rokitamycin on Campylobacter enteritis. Research Group of Rokitamycin on Infectious Enteritis].
Irimajiri S; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Sato J; Tsunoda T; Ota S; Nakamura Y
Kansenshogaku Zasshi; 1991 Sep; 65(9):1153-64. PubMed ID: 1761895
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field].
Toyonaga Y; Sugita M; Joh K; Takahashi T; Watanabe Y; Hori M
Jpn J Antibiot; 1988 Jun; 41(6):720-38. PubMed ID: 3265445
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
Imagawa Y; Fukuyama M; Kawakami K; Suda O
Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
Obana M; Matsuoka Y; Irimajiri S; Tonooka H
Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of effectiveness of rokitamycin dry syrup in acute enteritis in pediatrics. A comparative study on rokitamycin and fosfomycin dry syrups].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Sakata Y; Yamashita F; Suzuki K; Ishii M
Jpn J Antibiot; 1990 Feb; 43(2):257-84. PubMed ID: 2194055
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of rokitamycin against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory and clinical studies of rokitamycin dry syrup in the field of pediatrics].
Kuno K; Nakao Y; Yamamoto N; Hayakawa F; Ishikawa H; Kimura H; Takeuchi H
Jpn J Antibiot; 1988 Jul; 41(7):875-84. PubMed ID: 3172461
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
Fukuyama M; Oonaka K; Hara M; Imagawa Y
Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of in vitro activity of rokitamycin against Chlamydia trachomatis].
Bannai H; Miyano A; Miyazawa H; Ashihara Y
Kansenshogaku Zasshi; 1990 Jun; 64(6):687-92. PubMed ID: 2401815
[TBL] [Abstract][Full Text] [Related]
16. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Okubo T; Iyobe S; Fujiki Y; Sagai H
Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
[TBL] [Abstract][Full Text] [Related]
19. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Fukuyama M; Kawakami K; Suda O; Imagawa Y
Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
